MoneyWorks4Me

Colinz Laboratories - Quaterly Results

30 Jul 2022 Evaluate
Revenue reduced marginally to stand at Rs. 18.38 millions during the quarter ended June 2022. The figure stood at Rs. 18.50 millions during the year-ago period.The company has announced a 32.53% increase in its profits to Rs . 1.10  millions for the  quarter ended June 2022 compared to Rs. 0.83 millions in the corresponding quarter in the previous year.Operating profit surged to 1.87 millions from the corresponding previous quarter of 1.81 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 18.38 18.50 -0.65 18.38 18.50 -0.65 69.74 61.59 13.23
Other Income 0.41 0.41 0.00 0.41 0.41 0.00 1.71 1.91 -10.47
PBIDT 1.87 1.81 3.31 1.87 1.81 3.31 7.57 5.22 45.02
Interest 0.12 0.20 -40.00 0.12 0.20 -40.00 0.76 0.87 -12.64
PBDT 1.75 1.61 8.70 1.75 1.61 8.70 6.81 4.35 56.55
Depreciation 0.32 0.50 -36.00 0.32 0.50 -36.00 2.01 1.91 5.24
PBT 1.43 1.11 28.83 1.43 1.11 28.83 4.80 2.44 96.72
TAX 0.33 0.28 17.86 0.33 0.28 17.86 1.41 0.38 271.05
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.09 -0.40 -77.50
PAT 1.10 0.83 32.53 1.10 0.83 32.53 3.39 2.06 64.56
Equity 25.19 45.71 -44.89 25.19 45.71 -44.89 35.45 35.45 0.00
PBIDTM(%) 10.17 9.78 3.99 10.17 9.78 3.99 10.85 8.48 28.07
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..